These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4593805)

  • 1. Orthotopic liver transplantation in canine hemophilia B.
    Webster WP; Mandel SR; Reddick RL; Wagner JL; Penick GD
    Am J Physiol; 1974 Mar; 226(3):496-500. PubMed ID: 4593805
    [No Abstract]   [Full Text] [Related]  

  • 2. Orthotopic liver transplantation totally corrects factor IX deficiency in hemophilia B.
    Merion RM; Delius RE; Campbell DA; Turcotte JG
    Surgery; 1988 Nov; 104(5):929-31. PubMed ID: 3055399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of recombinant factor IX and thromboelastography in a patient with hemophilia B undergoing liver transplantation: a case report.
    De Pietri L; Masetti M; Montalti R; Begliomini B; Reggiani A; Barbieri E; Biagioni E; Marietta M; Romano A; Pasetto A; Gerunda GE
    Transplant Proc; 2008; 40(6):2077-9. PubMed ID: 18675136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthotopic liver transplantation in hemophilia B: a case report.
    Kadry Z; de Moerloose P; Giostra E; Morel P; Huber O; Meili E; Blum HE; Mentha G
    Transpl Int; 1995; 8(6):485-7. PubMed ID: 8579741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in coagulation and fibrinolysis after orthotopic canine liver homotransplantation.
    Pechet L; Groth CG; Daloze PM
    J Lab Clin Med; 1969 Jan; 73(1):91-102. PubMed ID: 4883102
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexes.
    Lozier JN; Thompson AR; Hu PC; Read M; Brinkhous KM; High KA; Curiel DT
    Hum Gene Ther; 1994 Mar; 5(3):313-22. PubMed ID: 8018746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver.
    Wang L; Nichols TC; Read MS; Bellinger DA; Verma IM
    Mol Ther; 2000 Feb; 1(2):154-8. PubMed ID: 10933925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple assay for human factor IX: use of canine hemophilia B plasma as substrate.
    Goldsmith JC; Chung KS; Roberts HR
    Thromb Res; 1978 Mar; 12(3):497-502. PubMed ID: 653637
    [No Abstract]   [Full Text] [Related]  

  • 9. Propagating factor IX-producing hepatocytes for haemophilia B therapy.
    Ofosu FA
    Thromb Haemost; 2008 May; 99(5):799-800. PubMed ID: 18449406
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic effects of hepatocyte transplantation on hemophilia B.
    Tatsumi K; Ohashi K; Shima M; Nakajima Y; Okano T; Yoshioka A
    Transplantation; 2008 Jul; 86(1):167-70. PubMed ID: 18622295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful in vivo propagation of factor IX-producing hepatocytes in mice: potential for cell-based therapy in haemophilia B.
    Tatsumi K; Ohashi K; Kataoka M; Tateno C; Shibata M; Naka H; Shima M; Hisanaga M; Kanehiro H; Okano T; Yoshizato K; Nakajima Y; Yoshioka A
    Thromb Haemost; 2008 May; 99(5):883-91. PubMed ID: 18449417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coronary artery bypass with extracorporeal circulation in a patient with hemophilia B].
    Bukowski JG; De Brux JL; Ganascia B; Cottineau C; Jacob JP
    Ann Fr Anesth Reanim; 1996; 15(3):304-6. PubMed ID: 8758585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthotopic liver transplantation for hepatitis C infection: the best Christmas present?
    Johnston SD; McNulty O; Mayne E; Callender ME
    Ulster Med J; 1998 Nov; 67(2):134-6. PubMed ID: 9885554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete deletion of factor IX gene and inhibition of factor IX activity in a labrador retriever with hemophilia B.
    Brooks MB; Gu W; Ray K
    J Am Vet Med Assoc; 1997 Dec; 211(11):1418-21. PubMed ID: 9394892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B.
    Liles D; Landen CN; Monroe DM; Lindley CM; Read MS; Roberts HR; Brinkhous KM
    Thromb Haemost; 1997 May; 77(5):944-8. PubMed ID: 9184407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Presence of inactive factor ix in variants of hemophilia, type B, and in carriers of hemophilia B].
    Elodi S
    Minerva Med; 1975 Jun; 66(42):2037-43. PubMed ID: 1138213
    [No Abstract]   [Full Text] [Related]  

  • 17. Preclinical experiment of auxiliary partial orthotopic liver transplantation as a curative treatment for hemophilia.
    Ko S; Tanaka I; Kanehiro H; Kanokogi H; Ori J; Shima M; Yoshioka A; Giles A; Nakajima Y
    Liver Transpl; 2005 May; 11(5):579-84. PubMed ID: 15838867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of auxiliary partial orthotopic liver transplantation for cure of hemophilia in a canine hemophilia A model.
    Ko S; Tanaka I; Kanokogi H; Kanehiro H; Okayama J; Ori J; Shima M; Yoshioka A; Giles A; Nakajima Y
    Transplant Proc; 2005 Mar; 37(2):1131-3. PubMed ID: 15848646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors.
    Snyder RO; Miao C; Meuse L; Tubb J; Donahue BA; Lin HF; Stafford DW; Patel S; Thompson AR; Nichols T; Read MS; Bellinger DA; Brinkhous KM; Kay MA
    Nat Med; 1999 Jan; 5(1):64-70. PubMed ID: 9883841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression.
    Fang B; Eisensmith RC; Wang H; Kay MA; Cross RE; Landen CN; Gordon G; Bellinger DA; Read MS; Hu PC
    Hum Gene Ther; 1995 Aug; 6(8):1039-44. PubMed ID: 7578416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.